Miyeon Jue
CTO

Apollon develops needle-free continuous glucose monitors utilizing breakthrough Raman-based sensing technology. Their MOGLU device offers accurate, comfortable, and compact glucose monitoring comparable to existing CGMs without requiring needles. This innovation removes barriers to better diabetes care through precision, non-invasive technology.
Raised to date
$2.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CTO